Cancer in Migrants: A Population-Based Study in Italy.
Italy
cancer epidemiology
migrants
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
08 Jun 2023
08 Jun 2023
Historique:
received:
20
03
2023
revised:
02
06
2023
accepted:
06
06
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Migrants are a vulnerable and neglected population. We aimed at investigating cancer proportionate rates in migrants in Sicily, Southern Italy. We extracted data on new cancer cases diagnosed between 2004 and 2019 from the Eastern Sicily cancer registry. We compared the adjusted proportionate morbidity ratio (PMR) for the most common cancer types among migrants and non-migrants. We fitted multivariate logistic regression models comparing one cancer to all other cancers to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for migration status. The analysis was stratified by region of origin. Overall, 4726 new cancer cases occurred in migrants between 2004 and 2019, 63.5% of those among women and 224,211 in non-migrants, including 54.5% among men, with odds for migrants/non-migrants of 2.1%. Migrants had an increased proportion of cervical (PMR = 2.68, 95% CI = 2.29-3.10) and lung cancer (PMR = 1.20, 95% CI = 1.07-1.33). The highest OR in migrants was observed for cervical cancer (OR = 3.54, 95% CI = 2.99-4.20). Colorectal cancer was decreased among migrants (OR = 0.86, 95% CI = 0.77-0.96). Migrants to Sicily have higher odds of cervical cancer and a decreased risk of colorectal cancer compared to non-migrants. Increased odds were also detected for lung cancer, in particular in women. Different cancer patterns could be observed based on the region of origin. HPV-related cancers need targeted attention in migrants living in Sicily.
Sections du résumé
BACKGROUND
BACKGROUND
Migrants are a vulnerable and neglected population. We aimed at investigating cancer proportionate rates in migrants in Sicily, Southern Italy.
METHODS
METHODS
We extracted data on new cancer cases diagnosed between 2004 and 2019 from the Eastern Sicily cancer registry. We compared the adjusted proportionate morbidity ratio (PMR) for the most common cancer types among migrants and non-migrants. We fitted multivariate logistic regression models comparing one cancer to all other cancers to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for migration status. The analysis was stratified by region of origin.
RESULTS
RESULTS
Overall, 4726 new cancer cases occurred in migrants between 2004 and 2019, 63.5% of those among women and 224,211 in non-migrants, including 54.5% among men, with odds for migrants/non-migrants of 2.1%. Migrants had an increased proportion of cervical (PMR = 2.68, 95% CI = 2.29-3.10) and lung cancer (PMR = 1.20, 95% CI = 1.07-1.33). The highest OR in migrants was observed for cervical cancer (OR = 3.54, 95% CI = 2.99-4.20). Colorectal cancer was decreased among migrants (OR = 0.86, 95% CI = 0.77-0.96).
CONCLUSIONS
CONCLUSIONS
Migrants to Sicily have higher odds of cervical cancer and a decreased risk of colorectal cancer compared to non-migrants. Increased odds were also detected for lung cancer, in particular in women. Different cancer patterns could be observed based on the region of origin. HPV-related cancers need targeted attention in migrants living in Sicily.
Identifiants
pubmed: 37370713
pii: cancers15123103
doi: 10.3390/cancers15123103
pmc: PMC10295978
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Epidemiol. 2021 Feb;54:64-72.e7
pubmed: 32950654
Public Health. 2020 Aug;185:189-195
pubmed: 32645506
Cancer Causes Control. 2009 May;20(4):459-71
pubmed: 19184626
PLoS One. 2018 Feb 20;13(2):e0192999
pubmed: 29462211
Eur J Prev Cardiol. 2015 Oct;22(10):1281-9
pubmed: 25261269
JAMA Otolaryngol Head Neck Surg. 2020 Dec 1;146(12):1125-1135
pubmed: 33151263
Gut. 2020 Jul;69(7):1218-1228
pubmed: 32066625
Nutrients. 2020 Jan 27;12(2):
pubmed: 32012681
Infect Dis Poverty. 2017 Feb 9;6(1):33
pubmed: 28179020
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13
pubmed: 24618998
Gynecol Oncol. 2014 Jun;133(3):409-15
pubmed: 24674831
Public Health Nutr. 2014 Dec;17(12):2650-9
pubmed: 24589249
Lancet Gastroenterol Hepatol. 2017 May;2(5):377-383
pubmed: 28397702
BMC Public Health. 2012 Aug 07;12:623
pubmed: 22871132
Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152
pubmed: 24259384
Cancer. 2017 Sep 1;123(17):3320-3325
pubmed: 28440952
Sex Transm Infect. 2013 Mar;89(2):91-7
pubmed: 22962070
Ann Glob Health. 2014 Sep-Oct;80(5):346-57
pubmed: 25512150
J Public Health (Oxf). 2021 Dec 10;43(4):814-823
pubmed: 32785597
Int J Environ Res Public Health. 2022 Sep 26;19(19):
pubmed: 36231502
Asian Pac J Cancer Prev. 2014;15(24):10565-71
pubmed: 25605140
Health Informatics J. 2019 Mar;25(1):149-160
pubmed: 28438105
Vaccine. 2009 May 29;27 Suppl 1:A6-10
pubmed: 19480964
Biometrika. 1950 Dec;37(3-4):256-66
pubmed: 14801052
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Hum Vaccin Immunother. 2019;15(7-8):1897-1903
pubmed: 30735451
Infect Agent Cancer. 2015 May 07;10:14
pubmed: 25969693
Addiction. 2018 Oct;113(10):1905-1926
pubmed: 29749059
Oncologist. 2011;16(2):146-54
pubmed: 21266400
Acta Radiol. 2018 Nov;59(11):1285-1291
pubmed: 29451023
Eur Urol. 2017 Jan;71(1):96-108
pubmed: 27370177
Int J Environ Res Public Health. 2021 Jul 27;18(15):
pubmed: 34360239
BMC Public Health. 2022 Mar 30;22(1):625
pubmed: 35354452
J Surg Oncol. 2021 Nov;124(6):920-922
pubmed: 34558067
Cancer. 2008 Nov 15;113(10 Suppl):2955-63
pubmed: 18980279
Eur J Cancer. 2010 Sep;46(14):2647-59
pubmed: 20843493
APMIS. 2011 Oct;119(10):701-9
pubmed: 21917007
Int J Environ Res Public Health. 2016 Dec 14;13(12):
pubmed: 27983668
Eur Urol. 2020 Jan;77(1):38-52
pubmed: 31493960
BMJ Open. 2018 Sep 19;8(9):e021653
pubmed: 30232106
Global Health. 2021 Jul 28;17(1):87
pubmed: 34321015
Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):903-909
pubmed: 32152216
Semin Radiat Oncol. 2017 Jan;27(1):3-10
pubmed: 27986209
J Natl Cancer Inst. 1981 Feb;66(2):217-25
pubmed: 6935472
Cancer. 2018 Apr 1;124(7):1473-1482
pubmed: 29315535
Nutrients. 2017 Sep 26;9(10):
pubmed: 28954418
Cancers (Basel). 2022 Aug 31;14(17):
pubmed: 36077790
Acta Oncol. 2020 Nov;59(11):1275-1283
pubmed: 32930622
J Infect Dis. 2010 Dec 15;202(12):1789-99
pubmed: 21067372
Lancet Oncol. 2017 Aug;18(8):e457-e471
pubmed: 28759385
Vaccine. 2022 Jan 24;40(3):471-476
pubmed: 34916103
Int J Environ Res Public Health. 2020 Jul 16;17(14):
pubmed: 32708556
Int J Urol. 2018 Jun;25(6):524-531
pubmed: 29740894
Cancer Med. 2018 May;7(5):2089-2100
pubmed: 29573569
Am J Gastroenterol. 2015 Apr;110(4):553-63
pubmed: 25756238
Lancet Oncol. 2022 Jun;23(6):719-728
pubmed: 35550275
Nutr Rev. 2008 Apr;66(4):203-15
pubmed: 18366534
Lancet Glob Health. 2018 Oct;6(10):e1077-e1086
pubmed: 30193830
Nutrients. 2018 Aug 10;10(8):
pubmed: 30103444
Nutrients. 2021 Feb 03;13(2):
pubmed: 33546190
Lancet. 2012 Nov 17;380(9855):1778-86
pubmed: 23117178